Expert Interview
Second View: Discussing the first blood test for diagnosing Alzheimer’s disease, developed by Japan-based Fujirebio Diagnostics.
Ticker(s): DGX, LLY, BIIB, LH, QTRX, FujirebioInstitution: Zucker Hillside Hospital
- Chief of Neurology at Zucker Hillside Hospital
- Professor of neurology and psychiatry at Donald and Barbara Zucker School of Medicine
- Manages 150 patients with Alzheimer's Disease
- Has been a Principal Investigator in clinical research studies of Alzheimer’s disease, mild cognitive impairment, and vascular dementia.
Are You Interested In These Questions?
Slingshot Insights Explained
- Call Date
- Sep 04, 2025
- Call Time
- 04:00 PM EDT
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
